NOIR 11% Dark Gray Medium Fitover Sunglasses
by NoIR
Last verified June 19, 2026 · classified April 26, 2026
What it is
Summary
AI-generated from vendor-published content · April 26, 2026
These are low-transmission fitover sunglasses that block 89% of visible light while providing full UV protection, designed to be worn directly over prescription eyeglasses. They're intended for people with light-sensitive eye conditions — including glaucoma, diabetic retinopathy, and those recovering from cataract surgery — who need significant glare reduction to see comfortably outdoors or in bright indoor environments. The dark gray tint preserves natural color perception rather than shifting how colors look, which matters for everyday tasks. These are a simple, complete solution on their own: no adjustments or professional fitting needed, though an eye care provider can help confirm whether 11% transmission or a different filter density is the right choice for a specific condition.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
What Setup Looks Like
- Out of the box
- Slide the fitover frame over your existing glasses — they are ready to wear immediately.
- No adjustment or tools required.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
As an Amazon Associate we earn from qualifying purchases.
Wondering how equipment like this gets paid for? See the official funding programs in your state.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from NoIR — view on vendor site; last verified June 19, 2026.
Classification & description AI-generated from vendor-published content on April 26, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.